ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma. | Huntsman Cancer Institute / Stephen Lessnick | Innovation Grants | 2009 | Utah |
Ectopic Neuroligin Signaling in Pediatric Glioblastoma | University of Utah / Alex Shcheglovitov, PhD | Innovation Grants | 2023 | Utah |
Modeling Pediatric Leukemia in Zebra Fish to Enable Discovery of New Anti- Leukemic Compounds | University of California, San Diego / David Traver, MD | Innovation Grants | 2010 | California |
Developmental origins of leukemia in Down Syndrome | University of Rochester / James Palis, MD & Laurie Steiner, MD | Innovation Grants | 2022 | New York |
Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma | Ann & Robert H. Lurie Children’s Hospital of Chicago / Oren Becher, MD & Robert Wechsler-Reya, PhD | Innovation Grants | 2019 | Illinois |
Blockade of MYCN in neuroblastoma | University of California San Francisco / William Weiss, MD/PhD | Innovation Grants | 2011 | California |
Developmental Therapeutics and Translational Research Program | Children’s Hospital of Philadelphia / John Maris | Phase I/II Infrastructure Grants | 2005 | Pennsylvania |
Pediatric Oncology Investigational Therapeutics. | Doernbecher Children’s Hospital Foundation / Linda Stork, MD | Phase I/II Infrastructure Grants | 2007 | Oregon |
Columbia University Developmental Therapeutics Program: Striving for Excellence | Columbia University / Julia Glade Bender, MD | Phase I/II Infrastructure Grants | 2013 | New York |
131-I-MIBG and Targeted Therapy for Neuroblastoma: Infrastructure Proposal. | University of California San Francisco / Katherine Matthay, MD | Phase I/II Infrastructure Grants | 2007 | California |